Published: Fri, May 19, 2017
Business | By Max Garcia

McKesson Shares Surge After Earnings, Outlook Top Street View

While the stock price moved along with the volume change, shares are touching $153.99.

McKesson Corporation (NYSE:MCK) stock was sitting pretty on Friday following the release of its earnings report for its fiscal fourth quarter of 2017. Following the completion of the sale, the chairman now owns 22,390 shares of the company's stock, valued at $3,368,351.60. We have $164.97 PT which if reached, will make NYSE:MCK worth $2.28B more.

Profund Advisors LLC lowered its stake in McKesson Co. According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $154.21 on company shares. The firm's revenue for the quarter was up 4.4% compared to the same quarter past year. Amgen Inc now has $117.17 billion valuation. The stock increased 0.64% or $0.02 on May 18, reaching $3.92.

About 686,430 shares traded. It has by 0.00% the S&P500.

Investors sentiment decreased to 1.09 in Q4 2016. Its up 0.03, from 1.21 in 2016Q3. South Texas Money Mgmt Ltd holds 2,868 shares or 0.02% of its portfolio. Wunderlich Capital Managemnt holds 1.27% or 10,699 shares in its portfolio. Carnegie Capital Asset Mngmt holds 0.76% or 39,201 shares. Thompson Siegel & Walmsley has 0% invested in Town Sports International Holdings, Inc. Ally Inc owns 20,000 shares or 0.47% of their USA portfolio. (NASDAQ:CLUB) for 26,100 shares. Mcf Advisors invested in 0.03% or 1,076 shares. M&R Capital Mgmt reported 100 shares.

In other news, Chairman John H. Hammergren sold 100,500 shares of the business's stock in a transaction on Wednesday, March 29th.

Schroder Investment Management Group is a Maine-based institutional investor with more than $42.96 billion AUM in July, 2014. Inr Advisory Svcs Llc holds 11 shares. The business had revenue of $48.71 billion during the quarter, compared to analyst estimates of $49.48 billion. It has a 24.97 P/E ratio.

During its fourth fiscal quarter of 2017, McKesson Corporation reported earnings per share of $3.42.

Among 19 analysts covering Amgen Inc. They issued a "hold" rating for the company. Therefore 50% are positive. The rating was initiated by Credit Suisse with "Outperform" on Wednesday, January 20. McKesson has a consensus rating of "Hold" and a consensus target price of $169.34. As per Tuesday, June 7, the company rating was maintained by Bank of America. The rating was initiated by Leerink Swann with "Market Perform" on Friday, February 5. The company was initiated on Thursday, October 6 by UBS. On Wednesday, November 23 the stock rating was downgraded by Credit Suisse to "Underperform". On Friday, September 16 the stock rating was downgraded by Goldman Sachs to "Neutral". Spatafora Carolyn had sold 3,001 shares worth $12,156 on Monday, March 6.

Investors sentiment decreased to 0.68 in 2016 Q4. Its down 0.38, from 1.06 in 2016Q3. It dropped, as 140 investors sold MCK shares while 331 reduced holdings. 90 funds opened positions while 232 raised stakes. Sivik Glob Health Ltd Limited Liability Company reported 35,000 shares. 4,138 were accumulated by Montag A & Associate Incorporated.

As of writing, McKesson Corporation's RSI stands at 68.69. Argent Tru has 3,405 shares. Corporate insiders own 1.15% of the company's stock. McKesson had a return on equity of 30.05% and a net margin of 0.97%. Trust Of Vermont reported 1,706 shares. The original version of this story can be accessed at 15,043 were reported by Clean Yield Gru.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The firm set "Hold" rating on the $29.54 billion market cap company. The Firm operates through three divisions: Wood Products, Building Materials Distribution, and Corporate and Other. In North America, market growth and acquisition activity produced a 5% rise, while worldwide pharmaceutical distribution saw the same rise despite a seven-percentage-point currency hit.

Like this: